What's new

EMEA-001949-PIP02-18-M04

EMEA-001949-PIP02-18-M04

Mar 14, 2025 - 11:39
 0
EMEA-001949-PIP02-18-M04
EMEA-001949-PIP02-18-M04
Read More

Tags:

Previous Article

The Competitive Edge: Market Intelligence That Moves You Forward

Next Article

UP showcases mining technology offering

Related Posts

Orphan designation: human anti-promyostatin monoclonal antibody (apitegromab) Treatment of spinal muscular atrophy, 14/12/2018 Positive

Orphan designation: human anti-promyostatin monoclonal ...

Feb 24, 2025  0

Clinical Trials Information System

Clinical Trials Information System

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 6, 2025  0